Search

everythinglearnresearchcommunity

for

Search:↓

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Men have more severe COVID-19 outcomes than women.

Genetic differences affect COVID-19 severity and treatment development.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Balancing testosterone may reduce COVID-19 severity.